N/A Completed N=40 Treatment

Tetragraph® Monitor: Tolerance of Preoperative Placement

Surgery

Source: ClinicalTrials.gov NCT05964166 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2024

Primary outcomePrimary: Tolerance to Preop Placement as Assessed by Likert Scale — 0; 10; 0; 10 units on a scale (0-10)

Summary

This is a prospective, non-blinded, single arm study. The primary objective of this study is to evaluate the tolerance to preoperative placement of the adhesive sensor for the Tetragraph® Neuromuscular Transmission Monitor in pediatric-sized patients ≤ 12 years of age.

Outcome Measures

Outcome	Result	p-value
PRIMARY Tolerance to Preop Placement as Assessed by Likert Scale	0; 10; 0; 10	—
SECONDARY Application Ease	4; 10	—

Eligibility Criteria

Inclusion Criteria

Patients requiring anesthetic care and use of neuromuscular blockade
Age ≤ 12 years
ASA 1-4

Exclusion Criteria

History of a peripheral neurologic or neuropathic disorder
Upper extremity cannot be used for TOF monitoring
Undergoing a surgical procedure in which neuromuscular blockade is not required
Patient is edematous
Patients with significant behavioral or neurocognitive issues which affect behavior and impact the ability to place the sensor

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05964166). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.